Recently, the Second People's Hospital of Weifang City (Weifang Respiratory Disease Hospital) successfully carried out a case of superior vena cava stenting and pulmonary artery stent grafting, which supported the "life breathing channel" for the patient. This "two-pronged" operation is the first case in Weifang, which not only marks a new level of respiratory interventional treatment in the hospital, but also marks that the respiratory interventional treatment technology has reached the leading level in China.
Mr. Wang, 66 years old this year, has often experienced dizziness and headache in the past half a month, and his head, face and upper limbs have also been swollen. To this end, Mr. Wang came to the Second People's Hospital of Weifang City (Weifang Respiratory Disease Hospital) for treatment, and He Guanghui, director of the interventional department of the hospital, first performed a chest CT with contrast for Mr. Wang, which showed that the upper lobe of the right lung was occupied, the superior vena cava was occluded, and the right pulmonary artery was severely stenosis. At the same time, Mr. Wang's partial pressure of oxygen was extremely low. He Guanghui judged that the swelling of Mr. Wang's head, face and upper limbs was caused by superior vena cava syndrome caused by the lung mass, while the dyspnea and decreased partial pressure of oxygen were caused by the compression of the right pulmonary artery by the lung mass.
Superior vena cava syndrome (SVCS) is a group of symptoms caused by partial or complete obstruction of blood flow through the superior vena cava to the right atrium, and is a common acute condition of pulmonary mass. For Mr. Wang, without surgery, he would face a life-threatening life, and the risk of performing both superior vena cava stenting and pulmonary artery stent grafting at the same time was extremely high. To this end, after explaining the condition to Mr. Wang and his family, He Guanghui decided to lead his team to work closely with the surgical anesthesia team, and have the courage to take responsibility and face difficulties.
After a detailed demonstration of the feasibility of the operation and the possible emergencies during the operation, on the afternoon of April 22, He Guanghui led his team to start the operation, during the operation, Mr. Wang successfully placed the superior vena cava stent and pulmonary artery stent, opened the superior vena cava and the main trunk of the right pulmonary artery, during which the surgical team was seamless, and every action during the operation was done with caution, and the operation was finally smooth. After one night in the ICU ward, Mr. Zhao returned to the general ward the next day. Mr. Wang said happily, "After the operation, my headache and swelling have been reduced, my eyes can be opened, my chest is no longer stuffy, I have no problem walking on the ground, and I feel very relaxed." ”
Superior vena cava stenting and pulmonary artery stenting are the first-line treatment for superior vena cava syndrome and pulmonary artery stenosis, respectively, and are also the best clinical treatment methods. However, two different types of surgery are performed at the same time, which is extremely risky and can easily lead to unpredictable consequences. The success of this operation is not only a test of the team's clinical adaptability, but also an extreme challenge to the team's interventional technology.